Search for: "Risperdal and Invega Cases" Results 1 - 20 of 27
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2014, 8:00 am by Tom Lamb
Although case reports have alluded to this link between Risperdal and gynecomstia, or male breasts, we know that case reports alone cannot show a causal link between Risperdal and gynecomastia. [read post]
19 Mar 2014, 9:21 am by Ronald V. Miller, Jr.
 Researchers found a 69% increased risk of gynecomastia among users of Risperdal and Invega. [read post]
11 Oct 2013, 6:09 am by Ronald V. Miller, Jr.
We are seeing more and more legal claims alleging Risperdal and Invega are causing young men to grow breasts. [read post]
28 Feb 2014, 9:27 pm by Legal Reader
Our law firm is currently accepting cases on behalf of men and boys who took the drug Risperdal or Invega and developed gynecomastia or other side effects as a result. [read post]
19 Jul 2017, 2:30 pm by Scott
Contact the Risperdal lawyers at McDonald Worley for a FREE case evaluation. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
12 May 2011, 9:18 pm by Ben Vernia
The focus of these matters is the alleged promotion of RISPERDAL ® and INVEGA ® for off-label uses. [read post]
13 Nov 2013, 1:30 pm
To read the DOJ news release about the case and details of the settlement, link here. [read post]
7 Nov 2013, 11:24 pm by Jon Gelman
The pharmaceutical manufacturer will pay $1.673 billion to resolve the allegations of off-label marketing for Risperdal and sister drug Invega, the resolution marking the largest involving a single drug in U.S. history, and the third-largest healthcare fraud settlement involving one company, according to the U.S. [read post]
5 Nov 2013, 12:40 pm
His suit ultimately helped government attorneys build their case against Johnson & Johnson and helped initiate other whistleblower suits against the company in their marketing of the schizophrenia drugs Risperdal and Invega. [read post]
4 Nov 2013, 3:26 pm
Risperdal and Invega are approved to help those with schizophrenia while Natrecor is a heart failure drug. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
“The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” said Attorney General Eric Holder. [read post]
23 Dec 2014, 6:10 pm by Jon Gelman
Here’s a round up of some of the biggest false claims settlements and the subsequent whistleblower rewards from the last fiscal year:Johnson & JohnsonSettlement: $2.2 billion “to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration  and payment of kickbacks to physicians and to the… [read post]
8 Nov 2013, 12:51 pm by admin
Strom’s allegations, this settlement resolved criminal and civil liability arising from allegations relating to the prescription drugs Risperdal and Invega, including promotion for uses not approved as safe and effective by the FDA and payment of kickbacks to physicians and to Omnicare, the nation’s largest LTACH provider. [read post]
30 Jan 2018, 4:00 am by silverman_admin
Additionally, Invega (generic name Paliperidone) is prescribed for the same use. [read post]
21 Nov 2014, 12:10 pm by Greene LLP
For example, Johnson & Johnson and its subsidiaries paid $1.1 billion to resolve False Claims Act allegations related to prescription drugs Risperdal, Invega and Natrecor. [read post]
12 Oct 2015, 8:35 am by Gregory J. Brod
Other Drug Promotion Efforts Covered by the 2014 Settlement Additional claims of off-label marketing involved Invega, a newer antipsychotic, and Natrecor, a heart failure drug. [read post]